Parathyroid hormone-related protein (107-111) improves the bone regeneration potential of gelatin–glutaraldehyde biopolymer-coated hydroxyapatite
Source abstract
Abstract
Biopolymer-coated nanocrystalline hydroxyapatite (HA) made as macroporous foams which are degradable and flexible are promising candidates as orthopaedic implants. The C-terminal (107-111) epitope of parathyroid hormone-related protein (PTHrP) exhibits osteogenic properties. The main aim of this study was to evaluate whether PTHrP (107-111) loading into gelatin-glutaraldehyde biopolymer-coated HA (HAGlu) scaffolds would produce an optimal biomaterial for tissue engineering applications. HAGlu scaffolds with and without PTHrP (107-111) were implanted into a cavitary defect performed in both distal tibial metaphysis of adult rats. Animals were sacrificed after 4 weeks for histological, microcomputerized tomography and gene expression analysis of the callus. At this time, bone healing occurred only in the presence of PTHrP (107-111)-containing HAGlu implant, related to an increase in bone volume/tissue volume and trabecular thickness, cortical thickness and gene expression of osteocalcin and vascular cell adhesion molecule 1, but a decreased gene expression of Wnt inhibitors, SOST and dickkopf homolog 1. The autonomous osteogenic effect of the PTHrP (107-111)-loaded HAGlu scaffolds was confirmed in mouse and human osteoblastic cell cultures. Our findings demonstrate the advantage of loading PTHrP (107-111) into degradable HAGlu scaffolds for achieving an optimal biomaterial that is promising for low load bearing clinical applications.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Bone health and treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. The Bone and Joint Decade, 2005. www.boneandjointdecade.org.
2. Bone regeneration and stem cells10.1111/j.1582-4934.2010.01224.x ↗
3. A tissue engineering approach based on the use of bioceramics for bone repair10.1039/C2BM00071G ↗
4. Role of angiogenesis in bone formation
5. Bioceramics: from bone regeneration to cancer nanomedicine10.1002/adma.201101586 ↗
6. Ceramics and bone repair
7. Third-Generation Biomedical Materials10.1126/science.1067404 ↗
8. Osteoinduction, osteoconduction and osseointegration10.1007/s005860100282 ↗
9. Biopolymer-coated hydroxyapatite foams: a new antidote for heavy metal intoxication10.1039/c0jm01260b ↗
10. Novel biopolymers-coated hydroxyapatite foams for removing heavy metals from polluted water
11. Biological performance of hydroxyapatite–biopolymer foams: in vitro cell response10.1016/j.actbio.2011.09.019 ↗
12. In vivo osteointegration of three-dimensional crosslinked gelatin-coated hydroxyapatite foams10.1016/j.actbio.2012.06.019 ↗
13. Biomaterials as scaffold for bone tissue engineering10.1007/s00068-006-6047-8 ↗
14. Driscoll P. Orthopedic biomaterials market growth strongest in US. 2009. http://mediligence.com/blog/2009/01/30/orthopedic-biomaterials-market-growth-strongest-in-us/.
15. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies10.1016/j.bcp.2013.03.002 ↗
16. PTH and PTHrP signaling in osteoblasts10.1016/j.cellsig.2009.02.012 ↗
17. Parathyroid hormone-related protein-(107–139) inhibits bone resorption in vivo10.1210/endo.138.3.4990 ↗
18. Stimulation of osteoblast proliferation by C-terminal fragments of parathyroid hormone-related protein10.1359/jbmr.1999.14.6.915 ↗
19. The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low turnover osteopenia10.1111/j.1476-5381.2010.01155.x ↗
20. Role of the N- and C-terminal fragments of parathyroid hormone-related protein as putative therapies to improve bone regeneration under high glucocorticoid treatment10.1089/ten.tea.2009.0355 ↗
21. Comparison of the skeletal effects induced by daily administration of PTHrP (1–36) and PTHrP (107–139) to ovariectomized mice10.1002/jcp.22902 ↗
22. PTHrP (107-111) inhibits in vivo resorption that was stimulated by PTHrP (1-34) when applied intermittently to neonatal mice10.1007/s002239900359 ↗
23. A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts10.1210/endo-129-4-1762 ↗
24. C-terminal parathyroid hormone-related protein (PTHrP) (107-139) stimulates intracellular Ca2+ through a receptor different from the type 1 PTH/PTHrP receptor in osteoblastic osteosarcoma UMR 106 cells10.1210/endo.142.7.8276 ↗
25. Src kinases mediate VEGFR2 transactivation by the osteostatin domain of PTHrP to modulate osteoblastic function10.1002/jcb.24482 ↗
26. Osteostatin-loaded bioceramics stimulate osteoblastic growth and differentiation10.1016/j.actbio.2009.08.033 ↗
27. The osteoinductive properties of mesoporous silicate coated with osteostatin in a rabbit femur cavity defect model10.1016/j.biomaterials.2010.07.103 ↗
28. Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro10.1007/s00223-006-0099-y ↗
29. Osteostatin-loaded onto mesoporous ceramics improves the early phase of bone regeneration in a rabbit osteopenia model10.1016/j.actbio.2012.03.014 ↗
30. Evaporation-induced self-assembly: nanostructures made easy10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R ↗
31. A model for intramembranous ossification during fracture healing10.1016/S0736-0266(02)00017-7 ↗
32. Bone regeneration of rat tibial defect by zinc-tricalcium phosphate (Zn-TCP) synthesized from porous Foraminifera carbonate macrospheres10.3390/md11125148 ↗
33. Inhibition of the canonical Wnt pathway by high glucose can be reversed by parathyroid hormone-related protein in osteoblastic cells10.1002/jcb.24535 ↗
34. Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized on Si-doped hydroxyapatite in osteoblastic cells10.1016/j.actbio.2012.04.002 ↗
35. Recent advances in magnetic structure determination by neutron powder diffraction10.1016/0921-4526(93)90108-I ↗
36. Bone regeneration is regulated by Wnt signaling10.1359/jbmr.070802 ↗
37. Needle-like nano hydroxyapatite/poly(L-lactide acid) composite scaffold for bone tissue engineering application10.1016/j.msec.2008.07.038 ↗
38. Coraline bone graft substitutes10.1016/S0030-5898(05)70113-9 ↗
39. Evolution of bioceramics within the field of biomaterials10.1016/j.crci.2009.03.004 ↗
40. Animal models for implant biomaterial research in bone: a review10.22203/eCM.v013a01 ↗
41. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1 ↗
42. Angiogenesis: regulators and clinical applications10.1016/S0006-2952(00)00529-3 ↗
43. Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing10.1371/journal.pone.0016947 ↗
44. The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions10.1016/j.bone.2011.02.008 ↗
45. Treatment with N- and C-terminal peptides of parathyroid hormone-related protein partly compensate the skeletal abnormalities in igf-I deficient mice10.1371/journal.pone.0087536 ↗